Edgewise Therapeutics, Inc.

Report date
9/30/2026
Quarter
2026 Q3
Filed
11/2/2026
Shares
52,407
Value ($000)
2,128
Weight
0.0%
2025 Q1 - 2026 Q3 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).